Home and Office Wireless Router
Home and Office Wireless Router market is segmented by players, region (country), by Type and by ... Read More
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report 2024
1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Comparison by Application: (2022-2028)
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Estimates and Forecasts
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2017-2028
1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2017-2028
1.4.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Sites, Area Served, Product Type
2.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation and Trends
2.5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-steroidal Anti-inflammatory Drugs (NSAID) Players Market Share by Revenue
2.5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario by Region
3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
3.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.4.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
3.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Region
3.5.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
3.5.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.6.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
3.6.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
3.7.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Analysis by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2022)
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2022)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022)
5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Analysis by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2022)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2022)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Ecotrin
6.2.1 Ecotrin Corporation Information
6.2.2 Ecotrin Description and Business Overview
6.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.2.5 Ecotrin Recent Developments/Updates
6.3 Generic
6.3.1 Generic Corporation Information
6.3.2 Generic Description and Business Overview
6.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.3.5 Generic Recent Developments/Updates
6.4 St. Joseph
6.4.1 St. Joseph Corporation Information
6.4.2 St. Joseph Description and Business Overview
6.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.4.5 St. Joseph Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Merial
6.8.1 Merial Corporation Information
6.8.2 Merial Description and Business Overview
6.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.8.5 Merial Recent Developments/Updates
6.9 Merck Animal Health
6.9.1 Merck Animal Health Corporation Information
6.9.2 Merck Animal Health Description and Business Overview
6.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.9.5 Merck Animal Health Recent Developments/Updates
7 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Analysis
7.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
7.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
8.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
9 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Dynamics
9.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
9.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
9.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
9.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
10 Global Market Forecast
10.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2023-2028)
10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2023-2028)
10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Sites and Area Served
Table 11. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2022)
Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2022)
Table 19. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 20. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2022)
Table 21. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2022)
Table 23. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 24. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2022)
Table 25. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2022)
Table 33. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2022)
Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2022)
Table 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2017-2022)
Table 43. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2017-2022)
Table 45. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2022)
Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2017-2022)
Table 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022) & (USD/Unit)
Table 49. Bayer Corporation Information
Table 50. Bayer Description and Business Overview
Table 51. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 53. Bayer Recent Developments/Updates
Table 54. Ecotrin Corporation Information
Table 55. Ecotrin Description and Business Overview
Table 56. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 58. Ecotrin Recent Developments/Updates
Table 59. Generic Corporation Information
Table 60. Generic Description and Business Overview
Table 61. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 63. Generic Recent Developments/Updates
Table 64. St. Joseph Corporation Information
Table 65. St. Joseph Description and Business Overview
Table 66. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 68. St. Joseph Recent Developments/Updates
Table 69. Elanco Corporation Information
Table 70. Elanco Description and Business Overview
Table 71. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 73. Elanco Recent Developments/Updates
Table 74. Zoetis Corporation Information
Table 75. Zoetis Description and Business Overview
Table 76. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 78. Zoetis Recent Developments/Updates
Table 79. Boehringer Ingelheim Corporation Information
Table 80. Boehringer Ingelheim Description and Business Overview
Table 81. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 83. Boehringer Ingelheim Recent Developments/Updates
Table 84. Merial Corporation Information
Table 85. Merial Description and Business Overview
Table 86. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 88. Merial Recent Developments/Updates
Table 89. Merck Animal Health Corporation Information
Table 90. Merck Animal Health Description and Business Overview
Table 91. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 93. Merck Animal Health Recent Developments/Updates
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
Table 97. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List
Table 98. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Table 99. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
Table 100. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
Table 101. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Table 102. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2023-2028) & (K Units)
Table 103. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Forecast by Type (2023-2028)
Table 104. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 105. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share Forecast by Type (2023-2028)
Table 106. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2023-2028) & (K Units)
Table 107. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Forecast by Application (2023-2028)
Table 108. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 109. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share Forecast by Application (2023-2028)
Table 110. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Region (2023-2028) & (K Units)
Table 111. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Forecast by Region (2023-2028)
Table 112. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 113. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share Forecast by Region (2023-2028)
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type in 2021 & 2028
Figure 3. Salicylates Product Picture
Figure 4. Propionic acid derivatives Product Picture
Figure 5. Acetic acid derivatives Product Picture
Figure 6. Enolic acid (Oxicam) derivatives Product Picture
Figure 7. Anthranilic acid derivatives (Fenamates) Product Picture
Figure 8. Selective COX-2 inhibitors (Coxibs) Product Picture
Figure 9. Sulfonanilides Product Picture
Figure 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application in 2021 & 2028
Figure 11. Human
Figure 12. Animals
Figure 13. Others
Figure 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (2017-2028) & (US$ Million)
Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2017-2028) & (K Units)
Figure 17. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers in 2021
Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers in 2021
Figure 19. The Global 5 and 10 Largest Non-steroidal Anti-inflammatory Drugs (NSAID) Players: Market Share by Revenue in 2021
Figure 20. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2022)
Figure 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region in 2021
Figure 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2022)
Figure 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region in 2021
Figure 25. U.S. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Taiwan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Indonesia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Thailand Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Malaysia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Philippines Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Vietnam Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2017-2022)
Figure 50. Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure 51. Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure 52. Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer Ecotrin Generic St. Joseph Elanco Zoetis Boehringer Ingelheim Merial Merck Animal Health